Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Gilead Sciences
Brian G Feagan; Silvio Danese; Edward V Loftus; Séverine Vermeire; Stefan Schreiber; Timothy Ritter; Ronald Fogel; Rajiv Mehta; Sandeep Nijhawan; Radosław Kempiński; Rafał Filip; Ihor Hospodarskyy; Ursula Seidler; Frank Seibold; Ian L P Beales; Hyo Jong Kim; John McNally; Chohee Yun; Sally Zhao; Xiaopeng Liu; Chia-Hsiang Hsueh; Chantal Tasset; Robin Besuyen; Mamoru Watanabe; William J Sandborn; Gerhard Rogler; Toshifumi Hibi; Laurent Peyrin-Biroulet